Regulation Of Maternal Fuel Supply And Neonatal Adiposity
Completed
Conditions studied: Fetal Macrosomia, Gestational Diabetes
In brief
The purpose of this study is to determine whether unrecognized maternal hyperglycemia and postprandial lipemia early or late in gestation predicts excess neonatal adiposity.
Key facts
- Study ID
- NCT00826904
- Run by
- University of Colorado, Denver
- People needed
- 59
- Starts
- 2007-10-01
- Expected to finish
- 2017-03-20
- Last updated by the study team
- 2019-11-05
Who can join
Age: 18 and older, up to 35. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- Age 18 - 35 yr
- Pregnant (12-14 weeks gestation)
- Lean (BMI 20-26 kg/m2)
- Obese (BMI 30-38 kg/m2)
You may not qualify if…
- Age < 18 or > 35 yr
- Pre-existing diabetes
- Chronic medical conditions:
- hypertension,
- hepatitis,
- Human immunodeficiency Virus (HIV),
- Thrombophilias,
- History of:
- thromboembolism,
- renal disease,
- neurologic diseases,
- rheumatologic disorders,
- gastrointestinal disease,
- cardiac dysfunction, or
- pulmonary disease
- Obstetric conditions:
- history of stillbirth,
- severe growth restriction,
- severe preeclampsia, or
- placental abruption
- Medications known to affect lipid or glucose metabolism:
- Metformin,
- glucocorticoids,
- beta agonists or blockers, or
- antihypertensives
Where it is running
- University of Colorado Denver — Aurora, Colorado, United States
- University of Colorado Denver — Aurora, Colorado, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.